دورية أكاديمية

Interfacially Engineered Pyridinium Pseudogemini Surfactants as Versatile and Efficient Supramolecular Delivery Systems for DNA, siRNA, and mRNA.

التفاصيل البيبلوغرافية
العنوان: Interfacially Engineered Pyridinium Pseudogemini Surfactants as Versatile and Efficient Supramolecular Delivery Systems for DNA, siRNA, and mRNA.
المؤلفون: Satyal U; Department of Pharmaceutical Sciences and Moulder Center of Drug Discovery Research, Temple University School of Pharmacy , Philadelphia, Pennsylvania 19140, United States., Draghici B; Department of Pharmaceutical Sciences and Moulder Center of Drug Discovery Research, Temple University School of Pharmacy , Philadelphia, Pennsylvania 19140, United States., Dragic LL; Department of Pharmaceutical Sciences and Moulder Center of Drug Discovery Research, Temple University School of Pharmacy , Philadelphia, Pennsylvania 19140, United States., Zhang Q; Department of Pharmaceutical Sciences and Moulder Center of Drug Discovery Research, Temple University School of Pharmacy , Philadelphia, Pennsylvania 19140, United States., Norris KW; Department of Pharmaceutical Sciences and Moulder Center of Drug Discovery Research, Temple University School of Pharmacy , Philadelphia, Pennsylvania 19140, United States., Madesh M, Brailoiu E, Ilies MA; Department of Pharmaceutical Sciences and Moulder Center of Drug Discovery Research, Temple University School of Pharmacy , Philadelphia, Pennsylvania 19140, United States.
المصدر: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2017 Sep 06; Vol. 9 (35), pp. 29481-29495. Date of Electronic Publication: 2017 Aug 25.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1944-8252 (Electronic) Linking ISSN: 19448244 NLM ISO Abbreviation: ACS Appl Mater Interfaces Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Washington, D.C. : American Chemical Society
مواضيع طبية MeSH: Surface-Active Agents/*chemistry, DNA ; RNA, Messenger ; RNA, Small Interfering ; Transfection
مستخلص: This article presents the synthesis, self-assembly, and biological activity as transfection agents for pDNA, siRNA, and mRNA of novel pyridinium pseudogemini surfactants, interfacially engineered from the most efficient gemini surfactants and lipids generated in our amphiphile research program. Formulation of novel amphiphiles in water revealed supramolecular properties very similar to those of gemini surfactants, despite their lipidlike charge/mass ratio. This dual character was found also to enhance endosomal escape and significantly increase the transfection efficiency. We were also successful in identifying the parameters governing the efficient delivery of pDNA, siRNA, and mRNA, drawing valuable structure-activity and structure-property relationships for each nucleic acid type, and establishing DNA/siRNA/mRNA comparisons. Several supramolecular complexes identified in this study proved to be extremely efficient nucleic acid delivery systems, displaying excellent serum stability and tissue penetration in three-dimensional organoids.
References: Cell. 2009 Feb 20;136(4):642-55. (PMID: 19239886)
J Colloid Interface Sci. 2004 Oct 1;278(1):53-62. (PMID: 15313637)
Phys Chem Chem Phys. 2013 Dec 21;15(47):20510-6. (PMID: 24177354)
J Med Chem. 2010 Feb 25;53(4):1496-508. (PMID: 20112994)
Biochim Biophys Acta. 2005 Aug 15;1714(2):71-84. (PMID: 16051183)
Nat Rev Cancer. 2015 Jul;15(7):387-95. (PMID: 26040603)
Science. 2013 Feb 15;339(6121):823-6. (PMID: 23287722)
Gene. 2013 Aug 10;525(2):162-9. (PMID: 23618815)
J Control Release. 2005 Nov 28;108(2-3):484-95. (PMID: 16181701)
Curr Pharm Des. 2002;8(27):2441-73. (PMID: 12369942)
Adv Drug Deliv Rev. 2014 Feb;66:110-6. (PMID: 24384374)
Mol Ther. 2011 May;19(5):822-3. (PMID: 21532608)
Eur J Pharm Biopharm. 2015 Jan;89:347-56. (PMID: 25513958)
Mol Pharm. 2015 Jun 1;12(6):1902-10. (PMID: 25941755)
Top Curr Chem. 2010;296:191-226. (PMID: 21504103)
Nature. 2015 Oct 15;526(7573):351-60. (PMID: 26469046)
Chempluschem. 2015 Jun;80(6):952-962. (PMID: 31973260)
J Am Chem Soc. 2011 Nov 16;133(45):18014-7. (PMID: 21985329)
Expert Opin Biol Ther. 2015;15(9):1337-48. (PMID: 26125492)
Biochim Biophys Acta. 1999 Nov 9;1461(1):47-57. (PMID: 10556487)
J Med Chem. 2015 May 28;58(10):4091-130. (PMID: 25658858)
Nature. 2012 Feb 15;482(7385):331-8. (PMID: 22337052)
Biochim Biophys Acta. 2013 Feb;1828(2):412-8. (PMID: 23092705)
Pharm Res. 2007 Mar;24(3):438-49. (PMID: 17252188)
Clin Cancer Res. 2012 Apr 1;18(7):1947-53. (PMID: 22317764)
Biomacromolecules. 2012 Dec 10;13(12):3926-37. (PMID: 23130552)
Gene Ther. 1996 Feb;3(2):163-72. (PMID: 8867864)
J Control Release. 2007 Nov 20;123(3):181-3. (PMID: 17935817)
Biomacromolecules. 2013 Aug 12;14(8):2750-64. (PMID: 23834644)
Annu Rev Biophys Biomol Struct. 2000;29:27-47. (PMID: 10940242)
Nat Rev Drug Discov. 2009 Feb;8(2):129-38. (PMID: 19180106)
Drug Deliv Transl Res. 2015 Jun;5(3):231-42. (PMID: 25787731)
J Biol Chem. 2013 Aug 2;288(31):22481-92. (PMID: 23814062)
Mol Pharm. 2014 Aug 4;11(8):2734-44. (PMID: 25020033)
J Gene Med. 2014 Mar-Apr;16(3-4):84-96. (PMID: 24753287)
Gene Ther. 1998 Jan;5(1):137-43. (PMID: 9536275)
Acc Chem Res. 2012 Jul 17;45(7):1153-62. (PMID: 22428908)
Biochim Biophys Acta. 2016 Dec;1858(12):3017-3023. (PMID: 27664498)
Mol Pharm. 2010 Aug 2;7(4):1311-7. (PMID: 20568694)
J Med Chem. 2002 Jan 3;45(1):99-114. (PMID: 11754582)
Mol Ther. 2009 May;17(5):767-77. (PMID: 19277019)
Langmuir. 2009 Oct 6;25(19):11703-12. (PMID: 19788223)
Cell Signal. 2011 Mar;23(3):516-21. (PMID: 20851765)
Curr Gene Ther. 2008 Oct;8(5):296-312. (PMID: 18855628)
Nature. 1998 Feb 19;391(6669):806-11. (PMID: 9486653)
J Med Chem. 2006 Jun 29;49(13):3872-87. (PMID: 16789743)
Nanomedicine (Lond). 2016 Feb;11(3):289-306. (PMID: 26785905)
Nat Commun. 2014 Jun 27;5:4277. (PMID: 24969323)
Biochim Biophys Acta. 2008 Oct;1778(10):2177-81. (PMID: 18489900)
ACS Appl Mater Interfaces. 2016 Aug 31;8(34):22457-67. (PMID: 27512894)
Mol Ther. 2013 Jun;21(6):1195-203. (PMID: 23568259)
J Med Chem. 2004 Jul 15;47(15):3744-54. (PMID: 15239653)
Adv Genet. 2014;88:71-110. (PMID: 25409604)
J Control Release. 2007 Nov 20;123(3):184-94. (PMID: 17913276)
J Biol Chem. 2015 Feb 27;290(9):5661-72. (PMID: 25555917)
Mol Pharm. 2014 Feb 3;11(2):545-59. (PMID: 24377350)
Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):444-8. (PMID: 1988944)
Chem Commun (Camb). 2009 Aug 21;(31):4632-56. (PMID: 19641799)
Biochim Biophys Acta. 1998 Jan 5;1368(1):115-28. (PMID: 9459590)
Biotechnol J. 2015 Sep;10(9):1370-89. (PMID: 26037687)
Int J Pharm. 2010 Apr 15;389(1-2):232-43. (PMID: 20080162)
Biomaterials. 2013 Sep;34(28):6906-21. (PMID: 23768782)
Nat Rev Genet. 2011 May;12(5):316-28. (PMID: 21468099)
Med Res Rev. 2014 Jan;34(1):1-44. (PMID: 22907528)
معلومات مُعتمدة: R01 GM109882 United States GM NIGMS NIH HHS; R01 HL086699 United States HL NHLBI NIH HHS; R01 HL119306 United States HL NHLBI NIH HHS; S10 RR022511 United States RR NCRR NIH HHS
فهرسة مساهمة: Keywords: DNA; amphiphile; mRNA; pyridinium; siRNA; transfection
المشرفين على المادة: 0 (RNA, Messenger)
0 (RNA, Small Interfering)
0 (Surface-Active Agents)
9007-49-2 (DNA)
تواريخ الأحداث: Date Created: 20170816 Date Completed: 20190115 Latest Revision: 20210101
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC7774514
DOI: 10.1021/acsami.7b07066
PMID: 28809098
قاعدة البيانات: MEDLINE
الوصف
تدمد:1944-8252
DOI:10.1021/acsami.7b07066